PSS Redux-: The Fall and Rise of a Physician Supply Company
PSS built a strikingly successful physician supply company in the 1980s and early 1990s through a combination of an aggressive, no-holds-barred approach to sales and a strategy that targeted solo practitioners and small physician groups. Everything was going swimmingly until the mid 1990s when the company fell prey to a series of bad breaks and a loss of coroprate focus that nearly drove it out of busines. Now, led by a new management team, the company is putting the pieces back together.
You may also be interested in...
Just five weeks before the US election, a Medtech Insight analysis shows medical device companies are spending more on Democrat Joe Biden’s campaign than on Republican Donald Trump’s.
Denmark’s Orphazyme has raised more funds to market its lead product, the heat shock protein amplifier, arimoclomol, in the US and Europe, and to evaluate the compound for other lysosomal storage and neurodegenerative disorders.
Pacific Biosciences of California and Aziyo Biologics both acquire new finance chiefs; Illumina hires a new chief marketing officer; WishBone Medical president moves over to take helm at Electromedical Products International; and more.